IMAGING NANOPARTICLES FOR DIAGNOSTIC & THERAPEUTIC USE IN MOUSE TISSUES BY XFM

纳米颗粒成像用于诊断

基本信息

  • 批准号:
    8168624
  • 负责人:
  • 金额:
    $ 1.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-01-01 至 2010-12-31
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this project is to test the feasibility of TiO2 and derivative nanoparticles (Co-Fe-TiO2 and Co-Fe-Au-TiO2) nanoparticles and nanoparticle bio-organic molecule nanocomposites as diagnostic and/or therapeutic vehicles. Our previous experiments in cultured cells have shown that TiO2-DNA nanocomposites have unique and novel biochemical properties that would be very suitable for biomedical uses (Paunesku, et al.. Nature Materials (2003) 2 (5):343-346). We have since developed several new nanoparticles, and we investigated different ways to induce cellular uptake of such nanoparticles/nanocomposites (Figure 1). Therefore, we are now poised to test these different nano-constructs in vivo, in mice. Our overall goals can be organized in two aims: Aim 1) Testing different nanoparticle derivatives of TiO2 for in vivo stability and distribution Aim 2) Testing different nanoparticle coatings for in vivo stability and establishing their effects on in vivo distribution. At the BioCAT beamline we are investigating presence of titanium, cobalt, iron, gold and relevant "biological" elements: P, S, Ca, Zn using X-ray fluorescence in different mouse tissue sections with large surface area. We inject the nanocomposites directly into tumor tissue or intravenously or intraperitoneally. We subsequently isolate different tissues, freeze and cryosection them. We look for overlap of Ti signal with fluorescence signals of other elements present in nanoparticles and map their presence in different areas of tissue by comparing these signals with the signals produced by P, S, Zn and other elements "naturally" present in tissues.
该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员(PI)可能已经从其他NIH来源获得了主要资金, 因此可以在其他清晰的条目中代表。列出的机构是 对于中心,这不一定是调查员的机构。 The purpose of this project is to test the feasibility of TiO2 and derivative nanoparticles (Co-Fe-TiO2 and Co-Fe-Au-TiO2) nanoparticles and nanoparticle bio-organic molecule nanocomposites as diagnostic and/or therapeutic vehicles. 我们以前在培养细胞中的实验表明,TiO2-DNA纳米复合材料具有独特而新颖的生化特性,非常适合生物医学用途(Paunesku等。自然材料(2003)2(5):343-346)。 此后,我们已经开发了几种新的纳米颗粒,并研究了不同的方法来诱导这种纳米颗粒/纳米复合材料的细胞摄取(图1)。 因此,我们现在准备在小鼠中测试体内这些不同的纳米构造。 Our overall goals can be organized in two aims: Aim 1) Testing different nanoparticle derivatives of TiO2 for in vivo stability and distribution Aim 2) Testing different nanoparticle coatings for in vivo stability and establishing their effects on in vivo distribution.在BioCat光束线上,我们正在研究钛,钴,铁,金和相关的“生物”元素的存在:P,S,Ca,Zn使用X射线荧光在不同的小鼠组织切片中具有较大的表面积。 我们将纳米复合材料直接注入肿瘤组织或静脉内或腹膜内。 随后,我们将不同的组织分离,冷冻和冷冻切除。 We look for overlap of Ti signal with fluorescence signals of other elements present in nanoparticles and map their presence in different areas of tissue by comparing these signals with the signals produced by P, S, Zn and other elements "naturally" present in tissues.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GAYLE E. WOLOSCHAK其他文献

GAYLE E. WOLOSCHAK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GAYLE E. WOLOSCHAK', 18)}}的其他基金

Dosimetry and health effects of internal radionuclides
内部放射性核素的剂量测定和健康影响
  • 批准号:
    10753881
  • 财政年份:
    2023
  • 资助金额:
    $ 1.62万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10589866
  • 财政年份:
    2022
  • 资助金额:
    $ 1.62万
  • 项目类别:
Multi-Scale Evaluation and Mitigation of Toxicities Following Internal Radionuclide Contamination
内部放射性核素污染后毒性的多尺度评估和减轻
  • 批准号:
    10327393
  • 财政年份:
    2022
  • 资助金额:
    $ 1.62万
  • 项目类别:
Project 3: Elemental Microscopy for Detection of Radionuclide Distribution and Development of Cell and Tissue Phantoms
项目 3:用于检测放射性核素分布和细胞和组织模型开发的元素显微镜
  • 批准号:
    10589884
  • 财政年份:
    2022
  • 资助金额:
    $ 1.62万
  • 项目类别:
Project 3: Elemental Microscopy for Detection of Radionuclide Distribution and Development of Cell and Tissue Phantoms
项目 3:用于检测放射性核素分布和细胞和组织模型开发的元素显微镜
  • 批准号:
    10327398
  • 财政年份:
    2022
  • 资助金额:
    $ 1.62万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10327394
  • 财政年份:
    2022
  • 资助金额:
    $ 1.62万
  • 项目类别:
Multi-Scale Evaluation and Mitigation of Toxicities Following Internal Radionuclide Contamination
内部放射性核素污染后毒性的多尺度评估和减轻
  • 批准号:
    10589865
  • 财政年份:
    2022
  • 资助金额:
    $ 1.62万
  • 项目类别:
Radiation induced cancer risk reduction as a function of dose protraction: interspecies comparison
辐射诱发的癌症风险降低作为剂量延长的函数:种间比较
  • 批准号:
    10216194
  • 财政年份:
    2017
  • 资助金额:
    $ 1.62万
  • 项目类别:
Radiation induced cancer risk reduction as a function of dose protraction: interspecies comparison
辐射诱发的癌症风险降低作为剂量延长的函数:种间比较
  • 批准号:
    9401815
  • 财政年份:
    2017
  • 资助金额:
    $ 1.62万
  • 项目类别:
Radiation induced cancer risk reduction as a function of dose protraction: interspecies comparison
辐射诱发的癌症风险降低作为剂量延长的函数:种间比较
  • 批准号:
    9980304
  • 财政年份:
    2017
  • 资助金额:
    $ 1.62万
  • 项目类别:

相似国自然基金

藻类微生物燃料电池CO2藻菌协同生化转化及阴极原位耦合光催化捕获
  • 批准号:
    52306222
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SPION与BMP-2磁生化信号耦合靶向新生骨精准改善成骨微环境的研究
  • 批准号:
    82370930
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
耦合生物物理与生化地球化学过程的土地覆被变化多尺度气候效应研究
  • 批准号:
    42371102
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
入核效应蛋白SidW的生化及生物学功能
  • 批准号:
    32370196
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
力信号与生化信号协同调制免疫细胞两个关键界面过程的生物物理研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目

相似海外基金

Targeting Myosin to Treat Polycystic Kidney Disease
靶向肌球蛋白治疗多囊肾
  • 批准号:
    10699859
  • 财政年份:
    2023
  • 资助金额:
    $ 1.62万
  • 项目类别:
Programming of Epigenetic Clocks and Biomarkers from Early-life Arsenic Exposure
生命早期砷暴露的表观遗传时钟和生物标志物的编程
  • 批准号:
    10726009
  • 财政年份:
    2023
  • 资助金额:
    $ 1.62万
  • 项目类别:
lncRNA Function and Mechanisms during Cardiac Development and Disease
心脏发育和疾病过程中lncRNA的功能和机制
  • 批准号:
    10608600
  • 财政年份:
    2023
  • 资助金额:
    $ 1.62万
  • 项目类别:
Repetitive Stretch-Induced Myocardial Stiffening in Chronic Coronary Artery Disease
慢性冠状动脉疾病中反复牵拉引起的心肌硬化
  • 批准号:
    10588929
  • 财政年份:
    2023
  • 资助金额:
    $ 1.62万
  • 项目类别:
Diagnostic aptamer reagents to develop multi-analyte blood test for pre-clinical, mild and moderate Alzheimer's disease
诊断适体试剂用于开发针对临床前、轻度和中度阿尔茨海默病的多分析物血液检测
  • 批准号:
    10597840
  • 财政年份:
    2023
  • 资助金额:
    $ 1.62万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了